Literature DB >> 12070012

Transcriptional regulation of myeloid differentiation primary response (MyD) genes during myeloid differentiation is mediated by nuclear factor Y.

Robert M Tjin Tham Sjin1, Kandasamy Krishnaraju, Barbara Hoffman, Dan A Liebermann.   

Abstract

To understand the molecular mechanism by which interleukin-6 (IL-6) regulates myeloid differentiation primary response (MyD) genes at the onset of M1 myeloid differentiation, we used JunB as a representative MyD gene to isolate and characterize IL-6 responsive elements. An IL-6 responsive element was localized between -65 and -52 of the JunB promoter (-65/-52 IL-6RE). By using antibody and oligonucleotide competition assays in electrophoretic mobility shift assay experiments, we have shown that the heterotrimeric transcription nuclear factor Y (NF-Y) complex binds to this element. A dominant-negative form of NF-YA, ectopically expressed in M1 cells, blocked NF-Y binding to the -65/-52 IL-6RE and reduced induction of JunB by IL-6. Furthermore, inhibition of NF-Y binding also reduced MyD gene induction by IL-6 and dampened the IL-6-induced M1 differentiation program. These findings are consistent with the observation that most MyD genes contain intact NF-Y binding motifs in their promoter regions. In contrast to M1 cells, during myeloid differentiation of bone marrow (BM), there was induction of NF-Y binding to the -65/-52 IL-6RE. This induced binding can be attributed to the observed induction of NF-YA protein expression and may reflect the molecular mechanism that couples proliferation to terminal differentiation of normal myeloblasts. Similar to M1 cells, blocking NF-Y binding in BM resulted in a reduction in mature macrophages. It can be concluded that NF-Y plays a role in the transcriptional regulation of MyD genes and is required for optimum myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12070012     DOI: 10.1182/blood.v100.1.80

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.

Authors:  Sanggyu Lee; Jianjun Chen; Guolin Zhou; Run Zhang Shi; Gerard G Bouffard; Masha Kocherginsky; Xijin Ge; Miao Sun; Nimanthi Jayathilaka; Yeong Cheol Kim; Neelmini Emmanuel; Stefan K Bohlander; Mark Minden; Justin Kline; Ozden Ozer; Richard A Larson; Michelle M LeBeau; Eric D Green; Jeffery Trent; Theodore Karrison; Piu Paul Liu; San Ming Wang; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

2.  Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development.

Authors:  Erika W Lamb; Colleen D Walls; John T Pesce; Diana K Riner; Sean K Maynard; Emily T Crow; Thomas A Wynn; Brian C Schaefer; Stephen J Davies
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

3.  Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling.

Authors:  Shuo Chen; Jelica Gluhak-Heinrich; Marcos Martinez; Tong Li; Yimin Wu; Hui-Hsiu Chuang; Lei Chen; Juan Dong; Isabel Gay; Mary MacDougall
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

Review 4.  Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment.

Authors:  Paola Allavena; Cristina Belgiovine; Elisabeth Digifico; Roberta Frapolli; Maurizio D'Incalci
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

5.  Motif discovery in promoters of genes co-localized and co-expressed during myeloid cells differentiation.

Authors:  Alessandro Coppe; Francesco Ferrari; Andrea Bisognin; Gian Antonio Danieli; Sergio Ferrari; Silvio Bicciato; Stefania Bortoluzzi
Journal:  Nucleic Acids Res       Date:  2008-12-05       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.